Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21

Molecular Therapy - Oncolytics - Tập 17 - Trang 306-319 - 2020
Cheng Wu1, Ergang Guo1, Jun Ming1, Wei Sun1, Xin Nie1, Lu Sun1, Shan Peng1, Min Luo1, Dongbo Liu1, Linli Zhang1, Qi Mei1, Guoxian Long1, Guangyuan Hu1, Guoqing Hu1
1Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, Wuhan, People’s Republic of China

Tài liệu tham khảo

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394, 10.3322/caac.21492 Chen, 2019, Nasopharyngeal carcinoma, Lancet, 394, 64, 10.1016/S0140-6736(19)30956-0 Zhang, 2019, Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma, N. Engl. J. Med., 381, 1124, 10.1056/NEJMoa1905287 Mohammad, 2019, Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer, Nat. Med., 25, 403, 10.1038/s41591-019-0376-8 Lyko, 2018, The DNA methyltransferase family: a versatile toolkit for epigenetic regulation, Nat. Rev. Genet., 19, 81, 10.1038/nrg.2017.80 Zhu, 2004, 5-Aza-2′-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation, J. Biol. Chem., 279, 15161, 10.1074/jbc.M311703200 Montalban-Bravo, 2018, Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management, Am. J. Hematol., 93, 129, 10.1002/ajh.24930 Agrawal, 2018, Nucleosidic DNA demethylating epigenetic drugs—a comprehensive review from discovery to clinic, Pharmacol. Ther., 188, 45, 10.1016/j.pharmthera.2018.02.006 Jiang, 2014, 5-Azacytidine enhances the radiosensitivity of CNE2 and SUNE1 cells in vitro and in vivo possibly by altering DNA methylation, PLoS ONE, 9, e93273, 10.1371/journal.pone.0093273 Wang, 2014, Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation, Mol. Cancer Ther., 13, 3163, 10.1158/1535-7163.MCT-14-0317 Linhart, 2007, Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing, Genes Dev., 21, 3110, 10.1101/gad.1594007 Yang, 2014, DNMT3B overexpression by deregulation of FOXO3a-mediated transcription repression and MDM2 overexpression in lung cancer, J Thorac Oncol, 9, 1305, 10.1097/JTO.0000000000000240 Chen, 2016, Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines, BMC Cancer, 16, 431, 10.1186/s12885-016-2468-x Roll, 2008, DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines, Mol. Cancer, 7, 15, 10.1186/1476-4598-7-15 Nosho, 2009, DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer, Clin Cancer Res, 15, 3663, 10.1158/1078-0432.CCR-08-2383 Girault, 2003, Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas, Clin Cancer Res, 9, 4415 Amara, 2010, DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas, Cancer Sci., 101, 1722, 10.1111/j.1349-7006.2010.01569.x Hayette, 2012, High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia, PLoS ONE, 7, e51527, 10.1371/journal.pone.0051527 Chen, 2012, The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma, Cancer, 118, 4074, 10.1002/cncr.26736 Xue, 2015, A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation, Cancer Lett., 361, 121, 10.1016/j.canlet.2015.02.046 Bieging, 2014, Unravelling mechanisms of p53-mediated tumour suppression, Nat. Rev. Cancer, 14, 359, 10.1038/nrc3711 Gudkov, 2003, The role of p53 in determining sensitivity to radiotherapy, Nat. Rev. Cancer, 3, 117, 10.1038/nrc992 Bykov, 2018, Targeting mutant p53 for efficient cancer therapy, Nat. Rev. Cancer, 18, 89, 10.1038/nrc.2017.109 Liu, 2002, Novel gene therapy approach for nasopharyngeal carcinoma, Semin. Cancer Biol., 12, 505, 10.1016/S1044579X02000937 El-Deiry, 2016, p21(WAF1) mediates cell-cycle inhibition, relevant to cancer suppression and therapy, Cancer Res., 76, 5189, 10.1158/0008-5472.CAN-16-2055 Abbas, 2009, p21 in cancer: intricate networks and multiple activities, Nat. Rev. Cancer, 9, 400, 10.1038/nrc2657 Nie, 2019, SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway, Cancer Med., 8, 1779, 10.1002/cam4.2056 Seo, 2008, Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-β2 expression via DNA methylation, Cancer Lett., 270, 66, 10.1016/j.canlet.2008.04.043 Peng, 2016, Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene, Oncotarget, 7, 40025, 10.18632/oncotarget.9474 Pawlik, 2004, Role of cell cycle in mediating sensitivity to radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 59, 928, 10.1016/j.ijrobp.2004.03.005 Liu, 2015, IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation, Int. J. Cancer, 136, 547, 10.1002/ijc.29033 Liu, 2018, Downregulation of DNMT3A by miR-708-5p inhibits lung cancer stem cell-like phenotypes through repressing Wnt/β-catenin signaling, Clin Cancer Res, 24, 1748, 10.1158/1078-0432.CCR-17-1169 Yang, 2014, Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway, Cancer Lett., 344, 260, 10.1016/j.canlet.2013.11.006 Pan, 2009, Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma, J. Clin. Oncol., 27, 799, 10.1200/JCO.2008.18.9670 Mello, 2018, Deciphering p53 signaling in tumor suppression, Curr. Opin. Cell Biol., 51, 65, 10.1016/j.ceb.2017.11.005 Yu, 2019, Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition, Oncogene, 38, 549, 10.1038/s41388-018-0460-4 Zhou, 2016, Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation, Oncotarget, 7, 20691, 10.18632/oncotarget.7842 Cao, 2016, miR-125b targets DNMT3b and mediates p53 DNA methylation involving in the vascular smooth muscle cells proliferation induced by homocysteine, Exp. Cell Res., 347, 95, 10.1016/j.yexcr.2016.07.007 Zheng, 2006, p21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation, J. Cell. Biochem., 98, 1230, 10.1002/jcb.20838 Powell, 2014, Contribution of p53 to metastasis, Cancer Discov., 4, 405, 10.1158/2159-8290.CD-13-0136 Chang, 2011, p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs, Nat. Cell Biol., 13, 317, 10.1038/ncb2173 Luo, 2019, FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway, Cancer Lett., 455, 26, 10.1016/j.canlet.2019.04.019 Chan, 2008, Authentication of nasopharyngeal carcinoma tumor lines, Int. J. Cancer, 122, 2169, 10.1002/ijc.23374